Label: ANACIN- asprin and caffeine tablet
-
NDC Code(s):
63736-200-04,
63736-200-30,
63736-200-50,
63736-200-90, view more63736-200-91, 63736-200-92, 63736-200-93, 63736-200-95
- Packager: Insight Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 23, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredients (per tablet)
- Purposes
- Uses
-
Warnings
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Allergy alert:
Aspirin may cause a severe allergic reaction which may include:
- hives
- facial swelling
- asthma (wheezing)
- shock
Stomach bleeding warning
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
- are age 60 or older
- have had stomach ulcers or bleeding problems
- take a blood thinner (anticoagulant) or steroid drug
- take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
- have 3 or more alcoholic drinks every day while using this product
- take more or for a longer time than directed
Caffeine warning
This product contains caffeine. Limit the use of caffeine-containing medications, foods or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.
Ask a doctor before use if
- the stomach bleeding warning applies to you
- you have a history of stomach problems, such as heartburn
- you have high blood pressure, heart disease, liver cirrhosis, or kidney disease
- you are taking a diuretic
- you have asthma
Ask a doctor or pharmacist before use if
you are taking a prescription drug for
- diabetes
- gout
- arthritis
Stop use and ask a doctor if
- an allergic reaction occurs. Seek medical help right away.
- you experience any of the following signs of stomach bleeding
- feel faint
- vomit blood
- have bloody or black stools
- have stomach pain that does not get better
- feel faint
- new symptoms occur
- ringing in the ears or loss of hearing occurs
- redness or swelling is present
- pain gets worse or lasts more than 10 days
- fever gets worse or lasts more than 3 days
- These may be signs of a serious condition
- hives
- Directions
- Inactive ingredients
- Questions?
- PRINCIPAL DISPLAY PANEL
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ANACIN
asprin and caffeine tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63736-200 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) ASPIRIN 400 mg CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E) CAFFEINE 32 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) HYPROMELLOSES (UNII: 3NXW29V3WO) MINERAL OIL (UNII: T5L8T28FGP) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM LAURYL SULFATE (UNII: 368GB5141J) STARCH, CORN (UNII: O8232NY3SJ) STEARIC ACID (UNII: 4ELV7Z65AP) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) TRIACETIN (UNII: XHX3C3X673) Product Characteristics Color white Score no score Shape ROUND Size 10mm Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63736-200-30 1 in 1 BOX 06/25/2009 06/30/2023 1 30 in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:63736-200-50 1 in 1 BOX 06/25/2009 12/22/2023 2 50 in 1 BOTTLE; Type 0: Not a Combination Product 3 NDC:63736-200-90 1 in 1 BOX 06/25/2009 3 100 in 1 BOTTLE; Type 0: Not a Combination Product 4 NDC:63736-200-91 1 in 1 BOX 06/25/2009 06/30/2023 4 130 in 1 BOTTLE; Type 0: Not a Combination Product 5 NDC:63736-200-92 125 in 1 BOX 06/25/2009 12/22/2023 5 1 in 1 POUCH; Type 0: Not a Combination Product 6 NDC:63736-200-93 1 in 1 BOX 06/25/2009 6 300 in 1 BOTTLE; Type 0: Not a Combination Product 7 NDC:63736-200-95 750 in 1 BOX 06/25/2009 06/30/2023 7 1 in 1 POUCH; Type 0: Not a Combination Product 8 NDC:63736-200-04 1 in 1 BOX 06/25/2009 06/30/2023 8 4 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M013 06/25/2009 Labeler - Insight Pharmaceuticals LLC (055665422)


